secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001570562-22-000149
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus amends Daewoong supply pact: exits Russia, revamps Europe pricing
------------------------------------------------------------------------

- Evolus exits Russia; all rights to neurotoxin distribution revert to Daewoong.
- European pricing changed from fixed transfer price to net-sales-based price with quarterly true-up.
- Transfer price renegotiated annually; floor price per vial set.
- Evolus must meet launch schedule and reporting obligations; failure allows Daewoong to revert pricing.
- Parties to cooperate on transferring Russia regulatory materials to Daewoong.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056222000149/0001570562-22-000149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056222000149/eols-20221212.htm
  HTML page:      https://secwatch.observer/filing/0001570562-22-000149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer